Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | (+)-Thienamycin | HCID 441128 | — |
| Reactant | Methyl methanimidate--hydrogen chloride (1/1) | HCID 12657462 | — |
| Solvent | Phosphate | HCID 1061 | — |
| Product | Imipenem | HCID 104838 | — |
Reaction Steps
Thienamycin (517 mg) is dissolved in pH 7 0.1 N phosphate buffer (25 ml) and cooled in an ice bath with magnetic stirring. The solution is adjusted to pH 8.5 using 2.5 N sodium hydroxide solution dispensed from an automatic burette. While maintaining a pH of 8.5, methyl formimidate hydrochloride (711 mg) is added portionwise over 2-3 minutes. After an additional 10 minutes, the pH of the solution is brought to 7.0 using 2.5 N hydrochloric acid. The solution is chromatographed on a column of XAD-2 resin (150 cc) which is eluted with water. The N-formimidoyl thienamycin derivative elutes in 1.5-2.0 column volumes (200-300 cc) and is lyophilized to a white solid (217 mg). UV (pH 7 0.1 N phosphate buffer) λmax 297 nm (8,590). ir (Nujol mull) 1767 cm-1 (β-lactam) ##STR75##
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04335043 |
|---|
| Source dataset | uspto-grants-1982_06 |
|---|
| ORD ID | ord-46242ce9aab7416e9097597b32590956 |
|---|
| Source note | uspto-grants-1982_06 |
|---|